Skip to main content

Biora Therapeutics, Inc.

BIORDelisted Jun 4, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001580063

Biora Therapeutics, Inc. was delisted on Jun 4, 2025; its insiders filed their last Form 4 on Dec 16, 2024; 21 institutions reported holding it in 13F filings for Q3 2024, worth $6.13M in total; no superinvestor held it.

Q2 2021 vs. Q1 2021

How the institutions holding Biora Therapeutics, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of BIOR: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders4842−6
Shares43.2M55.0M+11.8M (+27.4%)
Value$205.6M$196.5M−$9.16M (−4.5%)

New holders (16)

Institutions that held Biora Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to BIOR in Q2 2021
InstitutionSharesValue% of portfolio
Parian Global Management LP1,336,398$4.77M2.16%
D. E. Shaw & Co., Inc.242,109$864.0K0.00%
Ergoteles LLC81,700$292.0K0.01%
Tibra Equities Europe Ltd66,100$236.0K0.07%
Susquehanna Fundamental Investments, LLC63,900$228.0K0.00%
Two Sigma Securities, LLC50,786$181.0K0.05%
Raymond James & Associates22,000$79.0K0.00%
Squarepoint Ops LLC20,307$72.0K0.00%
Parametric Portfolio Associates LLC17,347$62.0K0.00%
Eagle Asset Management Inc15,935$56.0K0.00%
Cubist Systematic Strategies, LLC14,907$53.0K0.00%
LPL Financial LLC11,000$39.0K0.00%
Boothbay Fund Management, LLC10,000$36.0K0.00%
Point72 Hong Kong Ltd6,587$24.0K0.00%
Belvedere Trading LLC9,206$22.0K0.01%
Howe & Rusling Inc300$1.00K0.00%

Sold out (22)

Institutions that held Biora Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.